StreetInsider
Log in to your account:
Log in
Signup
Home
EPS Insider
Event Calendar
Conferences
Classic Site
Upgrade to SI Premium - Free Trial
Pfizer (PFE) PT Raised to $34 at Goldman Sachs
July 31, 2024 5:20 AM
Goldman Sachs analyst Chris Shibutani raised the price target on Pfizer (NYSE: PFE) to $34.00 (from $31.00) while maintaining a ...
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
Categories
Analyst Comments
Analyst PT Change
Next Articles
Pfizer (PFE) PT Raised to $32 at Barclays
July 31, 2024 5:06 AM
Form SC TO-C PFIZER INC Filed by: PFIZER INC
July 30, 2024 5:18 PM
Form 8-K PFIZER INC For: Jul 30
July 30, 2024 8:04 AM
Pfizer, JetBlue, PayPal rise premarket; Merck, CrowdStrike, Diageo fall
July 30, 2024 7:33 AM
Pfizer hikes full-year outlook as Q2 results top estimates; shares up
July 30, 2024 6:58 AM
Pfizer lifts profit forecast as investors await turnaround
July 30, 2024 6:51 AM
Pfizer (PFE) Tops Q2 EPS by 14c; raises guidance
July 30, 2024 6:47 AM
Pfizer Reports Strong Second-Quarter 2024 Results And Raises 2024 Guidance
July 30, 2024 6:45 AM
Fed meeting, Microsoft earns, BP dividend - what's moving markets
July 30, 2024 5:31 AM
Stocks expected to have increasing option volume: PFE PYPL IT SYY GLW SOFI JBLU FFIV SFM
July 30, 2024 4:50 AM
Pfizer (PFE) call put ratio 1.7 calls to 1 put into quarter results
July 29, 2024 11:26 AM
Pfizer (PFE) call put ratio 2.3 calls to 1 put into quarter results
July 29, 2024 5:31 AM
Popular stocks with increasing volume: GME F PFE COIN PLTR SMCI MMM CMG CRWD AVGO
July 29, 2024 5:17 AM
